Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in copd

HIGHLIGHTS

• who: Rania Dagher and collaborators from the Facultu00e9 de Mu00e9decine, Site Bichat, Paris, France, Laboratory of Excellence INFLAMEX, Universitu00e9 ParisCitu00e9, Paris, France, Sciences and AI, BioPharmaceuticals RandD, AstraZeneca, Gaithersburg, Nice, France, Lung Health Research Centre, Department of Pharmacology and Therapeutics, University have published the article: Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD, in the Journal: PLOS ONE of 12/05/2022
• what: This study provides insights into COPD heterogeneity and suggests that overexpression of factors involved in lung immunity/host defense cell fate/repair/ remodelling and mitochondrial . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.